H.C. Wainwright Starts Windtree Therapeutics (WINT) at Neutral, 'Istaroxime Poised to Navigate Late-Stage Development'
Go back to H.C. Wainwright Starts Windtree Therapeutics (WINT) at Neutral, 'Istaroxime Poised to Navigate Late-Stage Development'| (NASDAQ: WINT) | Delayed: 0.11 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.11 | 52 Week High | $4.42 | |||
| Open | $0.11 | 52 Week Low | $1.44 | |||
| Day High | $0.11 | P/E | N/A | |||
| Day Low | $0.11 | EPS | $0.00 | |||
| Volume | 6,127 | |||||

